NDA 018203

ABBOTT

FDA Drug Application

Application #018203

Application Sponsors

NDA 018203

ABBOTT

Marketing Status

• Discontinued: 001

Application Products

001

INJECTABLE;INJECTION

10% (10GM/100ML)

0

LIPOSYN 10%

SAFFLOWER OIL

FDA Submissions

TYPE 1; Type 1 - New Molecular Entity	ORIG	1	AP	1979-05-16	STANDARD
LABELING; Labeling	SUPPL	2	AP	1979-07-03
LABELING; Labeling	SUPPL	8	AP	1980-05-19
LABELING; Labeling	SUPPL	9	AP	1980-05-06
LABELING; Labeling	SUPPL	14	AP	1981-12-17
LABELING; Labeling	SUPPL	15	AP	1981-04-14
LABELING; Labeling	SUPPL	16	AP	1981-07-21
LABELING; Labeling	SUPPL	18	AP	1982-01-11
LABELING; Labeling	SUPPL	19	AP	1981-08-17
LABELING; Labeling	SUPPL	20	AP	1982-02-22
LABELING; Labeling	SUPPL	23	AP	1982-03-01
LABELING; Labeling	SUPPL	24	AP	1982-03-08
LABELING; Labeling	SUPPL	26	AP	1982-06-21
LABELING; Labeling	SUPPL	27	AP	1996-04-26
LABELING; Labeling	SUPPL	29	AP	1984-02-24

CDER Filings

ABBOTT

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18203
            [companyName] => ABBOTT
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIPOSYN 10%","activeIngredients":"SAFFLOWER OIL","strength":"10% (10GM\/100ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LIPOSYN 10%","submission":"SAFFLOWER OIL","actionType":"10% (10GM\/100ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)